Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation

Bone Marrow Transplantation volume 39, pages 677–686 (2007)Cite this article

Abstract

Adenovirus (adv) is a significant cause of morbidity and mortality in pediatric hematopoietic stem cell transplant recipients, and control of infection seems to require antigen-specific T cells. We evaluated the recovery of adv-specific cellular immunity in this patient population related to degree of T-cell immunosuppressive therapy and compared this to adv cellular immunity of normal donors. Over 12 months, we monitored for adv DNA in stool and blood of patients and in the blood of a normal donor group. Twenty-two pediatric hematopoietic stem cell transplant (HSCT) patients (14 months–20 years) who received matched-related (MRD n=6), mismatched related (Haplo n=6) or matched unrelated donor (MUD n=10) grafts, were followed and results compared to healthy controls (n=8). Adv was detected by polymerase chain reaction in blood and/or stool from 81.8% of patients on at least one occasion post-HSCT, but only 68% of patients developed symptomatic adv infections. Recovery of adv-specific T cells was significantly delayed in the MUD and Haplo recipients, whereas recovery in the MRD group was similar to levels detected in healthy donors within 30 days post-transplant. In conclusion, recipients of alternative donor transplants at our institution have significantly delayed adv-specific cellular immune recovery, which correlates to an increased risk of adv-associated morbidity and mortality.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Horwitz MS . Adenoviruses Fields Virology. Lippincott, Williams & Wilkins: Philadelphia, PA, USA, 2002.

    Google Scholar 

  2. Hale GA, Heslop HE, Krance RA, Brenner MK, Jayawardene D, Srivastava DK et al. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant 1999; 23: 277–282.

    Article  CAS  Google Scholar 

  3. Flomenberg P, Babbitt J, Drobyski WR, Ash RC, Carrigan DR, Sedmak GV et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 1994; 169: 775–781.

    Article  CAS  Google Scholar 

  4. Blanke C, Clark C, Broun ER, Tricot G, Cunningham I, Cornetta K et al. Evolving pathogens in allogeneic bone marrow transplantation: increased fatal adenoviral infections. Am J Med 1995; 99: 326–328.

    Article  CAS  Google Scholar 

  5. Baldwin A, Kingman H, Darville M, Foot AB, Grier D, Cornish JM et al. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant 2000; 26: 1333–1338.

    Article  CAS  Google Scholar 

  6. de Mezerville MH, Tellier R, Richardson S, Hebert D, Doyle J, Allen U . Adenoviral infections in pediatric transplant recipients: a hospital-based study. Pediatric Infect Dis J 2006; 25: 815–818.

    Article  Google Scholar 

  7. Walls T, Hawrami K, Ushiro-Lumb I, Shingadia D, Saha V, Shankar AG . Adenovirus infection after pediatric bone marrow transplantation: is treatment always necessary? Clin Infect Dis 2005; 40: 1244–1249.

    Article  Google Scholar 

  8. Howard DS, Phillips II GL, Reece DE, Munn RK, Henslee-Downey J, Pittard M et al. Adenovirus infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 1999; 29: 1494–1501.

    Article  CAS  Google Scholar 

  9. Runde V, Ross S, Trenschel R, Lagemann E, Basu O, Renzing-Kohler K et al. Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved iin a prospective multi center surveillance study. Bone Marrow Transplant 2001; 28: 51–57.

    Article  CAS  Google Scholar 

  10. Heemskerk B, Lankester AC, van Vreeswijk T, Beersma MF, Claas EC, Veltrop-Duits LA et al. Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. J Infect Dis 2005; 191: 520–530.

    Article  CAS  Google Scholar 

  11. Chakrabarti S, Mautner V, Osman H, Collingham KE, Fegan CD, Klapper PE et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 2002; 100: 1619–1627.

    Article  CAS  Google Scholar 

  12. Feuchtinger T, Lucke J, Hamprecht K, Richard C, Handgretinger R, Schumm M et al. Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 2005; 128: 503–509.

    Article  Google Scholar 

  13. Feuchtinger T, Richard C, Pfeiffer M, Neuhauser F, Lucke J, Handgretinger R et al. Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update. Clin Padiatrics 2006; 217: 339–344.

    Google Scholar 

  14. Leen AM, Myers GD, Bollard CM, Huls MH, Sili U, Gee AP et al. T-cell immunotherapy for adenoviral infections of stem-cell transplant recipients. Ann NY Acad Sci 2006; 1062: 104–115.

    Article  Google Scholar 

  15. Ljungman P, Ribaud P, Eyrich M, Matthes-Martin S, Einsele H, Bleakley M et al. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2003; 31: 481–486.

    Article  CAS  Google Scholar 

  16. Yusuf U, Hale GA, Carr J, Gu Z, Benaim E, Woodard P et al. Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation 2006; 81: 1398–1404.

    Article  CAS  Google Scholar 

  17. Popat U, Heslop HE, Durett A, May R, Krance RA, Brenner MK et al. Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation (RISCT) using antilymphocyte antibodies in patients with high-risk acute myeloid leukemia (AML). Bone Marrow Transplant 2006; 37: 547–552.

    Article  CAS  Google Scholar 

  18. Hongeng S, Krance RA, Bowman LC, Srivastava DK, Cunningham JM, Horwitz EM et al. Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia. Lancet 2006; 350: 767–771.

    Article  Google Scholar 

  19. Heim A, Ebnet C, Harste G, Pring-Akerblom P . Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J Med Virol 2003; 70: 228–239.

    Article  CAS  Google Scholar 

  20. Lion T, Baumgartinger R, Watzinger F, Matthes-Martin S, Suda M, Preuner S et al. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 2003; 102: 1114–1120.

    Article  CAS  Google Scholar 

  21. Leen AM, Sili U, Vanin EF, Jewell AM, Xie W, Vignali D et al. Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells. Blood 2004; 104: 2432–2440.

    Article  CAS  Google Scholar 

  22. Kalbfleisch JD, Prentice RL . The Statistical Analysis of Failure Time Data. John-Wiley: Hoboken, NJ, USA, 1980.

    Google Scholar 

  23. Gray RJ . A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Statist 1988; 16: 1141–1154.

    Article  Google Scholar 

  24. Gray B . cmprsk: Subdistribution Analysis of Competing Risks 2004. R package version 2.2.1. http://www.r-project.org, http://biowww.dfci.harvard.edu/~gray.

  25. Avivi I, Chakrabarti S, Milligan DW, Waldmann H, Hale GA, Osman H et al. Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab. Biol Blood Marrow Transplant 2004; 10: 186–194.

    Article  Google Scholar 

  26. Lenaerts L, Naesens L . Antiviral therapy for adenovirus infections. Antiviral Res 2006; 71: 172–180.

    Article  CAS  Google Scholar 

  27. Hoffman JA, Shah AJ, Ross LA, Kapoor N . Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006; 7: 388–394.

    Article  Google Scholar 

  28. Seidemann K, Heim A, Pfister ED, Koditz H, Beilken A, Sander A et al. Monitoring of adenovirus infection in pediatric transplant recipients by quantitative PCR: report of six cases and review of the literature. Am J Transplant 2004; 4: 2102–2108.

    Article  Google Scholar 

  29. Feuchtinger T, Lang P, Hamprecht K, Schumm M, Greil J, Jahn G et al. Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy. Exp Hematol 2004; 32: 282–289.

    Article  CAS  Google Scholar 

  30. Feuchtinger T, Matthes-Martin S, Richard C, Lion T, Fuhrer M, Hamprecht K et al. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 2006; 134: 64–76.

    Article  Google Scholar 

  31. Regn S, Raffegerst S, Chen X, Schendel D, Kolb HJ, Roskrow M . Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant. Bone Marrow Transplant 2001; 27: 53–64.

    Article  CAS  Google Scholar 

  32. Leen AM, Myers GD, Sili U, Huls MH, Weiss H, Leung KS et al. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat Med 2006; 12: 1160–1166.

    Article  CAS  Google Scholar 

  33. Leen AM, Sili U, Savoldo B, Jewell AM, Piedra PA, Brenner MK et al. Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications. Blood 2004; 103: 1011–1019.

    Article  CAS  Google Scholar 

  34. Amrolia PJ, Muccioli-Casadei G, Huls MH, Adams S, Durrett A, Gee A et al. Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplant. Blood 2006; 108: 1797–1808.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported in part by a NRSA Viral Oncology Training Grant to GDM, a Doris Duke Distinguished Clinical Scientist Award to HEH and an Amy Strelzer Manasevit Scholar award from the NMDP to CMB.

Author information

Authors and Affiliations

  1. Center for Cell and Gene Therapy, Baylor College of Medicine, The Methodist Hospital, and Texas Children's Hospital, Houston, TX, USA

    G D Myers, C M Bollard, C M Rooney, H E Heslop & A M Leen

  2. Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA

    G D Myers, C M Bollard, C M Rooney, H E Heslop & A M Leen

  3. Department of Medicine, Baylor College of Medicine, Houston, TX, USA

    C M Bollard, M-F Wu, H Weiss & H E Heslop

Authors
  1. G D Myers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C M Bollard
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M-F Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C M Rooney
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H E Heslop
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A M Leen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A M Leen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Myers, G., Bollard, C., Wu, MF. et al. Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation. Bone Marrow Transplant 39, 677–686 (2007). https://doi.org/10.1038/sj.bmt.1705645

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705645

Keywords

This article is cited by

Search

Advanced search

Quick links